Niantao Deng

5.2k total citations · 1 hit paper
29 papers, 1.5k citations indexed

About

Niantao Deng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Niantao Deng has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Niantao Deng's work include Cancer Genomics and Diagnostics (6 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). Niantao Deng is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). Niantao Deng collaborates with scholars based in Australia, Singapore and United States. Niantao Deng's co-authors include Patrick Tan, Sandra O’Toole, Kate Harvey, Amy D. Marshall, Jeff Holst, John E.J. Rasko, Charles G. Bailey, Christina Selinger, Jane Beith and Yongmei Feng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Diabetes.

In The Last Decade

Niantao Deng

28 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer

2015 478 citations Michelle van Geldermalsen, Qian Wang et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Niantao Deng Australia	18	968	676	329	175	143	29	1.5k
George K. Belka United States	19	1.1k 1.2×	472 0.7×	774 2.4×	146 0.8×	148 1.0×	26	1.9k
Xueli Pang China	18	547 0.6×	324 0.5×	247 0.8×	70 0.4×	36 0.3×	27	1.0k
Hong-Wu Chen United States	19	1.2k 1.3×	604 0.9×	305 0.9×	356 2.0×	30 0.2×	23	1.7k
Ànna Manzano Spain	22	1.2k 1.2×	876 1.3×	263 0.8×	70 0.4×	53 0.4×	41	1.8k
Jérôme Durivault France	17	977 1.0×	638 0.9×	297 0.9×	246 1.4×	202 1.4×	35	1.4k
Yun‐Xin Lu China	17	856 0.9×	640 0.9×	235 0.7×	183 1.0×	28 0.2×	40	1.2k
Willmar D. Patino United States	8	1.3k 1.3×	802 1.2×	400 1.2×	70 0.4×	27 0.2×	11	1.7k
Wendy W. Hwang‐Verslues Taiwan	17	818 0.8×	424 0.6×	546 1.7×	103 0.6×	13 0.1×	22	1.4k
Oona Delpuech United Kingdom	20	1.1k 1.1×	460 0.7×	433 1.3×	243 1.4×	75 0.5×	33	1.7k
Fanny Dupuy Canada	7	1.4k 1.4×	971 1.4×	471 1.4×	146 0.8×	34 0.2×	8	2.1k

Countries citing papers authored by Niantao Deng

Since Specialization

Citations

This map shows the geographic impact of Niantao Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niantao Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niantao Deng more than expected).

Fields of papers citing papers by Niantao Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niantao Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niantao Deng. The network helps show where Niantao Deng may publish in the future.

Co-authorship network of co-authors of Niantao Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Niantao Deng. A scholar is included among the top collaborators of Niantao Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niantao Deng. Niantao Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shore, Neal D., Christopher Pieczonka, Ralph J. Henderson, et al.. (2023). Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer. Urologic Oncology Seminars and Original Investigations. 41(11). 454.e9–454.e16. 2 indexed citations

Holliday, Holly, Jessica Yang, Iva Nikolić, et al.. (2022). miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma. Molecular Therapy. 30(3). 1119–1134. 11 indexed citations

Deng, Niantao, André E. Minoche, Kate Harvey, et al.. (2022). Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models. Breast Cancer Research. 24(1). 63–63. 7 indexed citations

Locke, Warwick J., Phuc‐Loi Luu, Qian Du, et al.. (2021). Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer. Clinical Epigenetics. 13(1). 226–226. 19 indexed citations

Lee, Christine U., Kristine J. Fernandez, Sarah Alexandrou, et al.. (2020). Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer. Cancers. 12(8). 2268–2268. 18 indexed citations

Castillo, Lesley, Adelaide I.J. Young, Amanda Mawson, et al.. (2019). MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. Oncogene. 39(8). 1821–1829. 16 indexed citations

Yu, Liang, Le Ying, Jesse J. Balic, et al.. (2018). Toll‐like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2. International Journal of Cancer. 144(12). 3056–3069. 50 indexed citations

Lin, Hui‐Ming, Iva Nikolić, Jessica Yang, et al.. (2018). MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer. Scientific Reports. 8(1). 7820–7820. 39 indexed citations

Etemadmoghadam, Dariush, C. Elizabeth Caldon, George Au‐Yeung, et al.. (2018). 19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomes. Gynecologic Oncology. 151(2). 327–336. 27 indexed citations

10.

Yeo, S.P. & Niantao Deng. (2017). Multi‐section branch‐line couplers for crossover application. Microwave and Optical Technology Letters. 59(7). 1625–1629. 4 indexed citations

11.

Reischmann, Nadine, Sanaz Taromi, Justin Mastroianni, et al.. (2017). The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior. EBioMedicine. 20. 79–97. 36 indexed citations

12.

West, Alison C., Ke Tang, Hazel Tye, et al.. (2017). Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer. Oncogene. 36(36). 5134–5144. 53 indexed citations

13.

Cutcutache, Ioana, Yuka Suzuki, John R. McPherson, et al.. (2015). Abundant copy-number loss of CYCLOPS and STOP genes in gastric adenocarcinoma. Gastric Cancer. 19(2). 453–465. 5 indexed citations

14.

Nguyen, Akira, Daniel Roden, Benjamin Elsworth, et al.. (2015). MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene. Breast Cancer Research. 17(1). 83–83. 40 indexed citations

15.

Geldermalsen, Michelle van, Qian Wang, Rajini Nagarajah, et al.. (2015). ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene. 35(24). 3201–3208. 478 indexed citations breakdown →

16.

Das, Kakoli, et al.. (2014). Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH. Cancer Letters. 353(2). 167–175. 46 indexed citations

17.

Das, Kakoli, Chia-Huey Ooi, Niantao Deng, et al.. (2011). Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer. Clinical Cancer Research. 17(9). 2657–2667. 172 indexed citations

18.

Tai, Wai Meng David, Wei Ooi, Joanne Ngeow, et al.. (2011). A phase I study of dovitinib in combination with capecitabine and oxaliplatin in upfront treatment of advanced colorectal and gastric cancer with a dose expansion cohort in advanced gastric cancer.. Journal of Clinical Oncology. 29(15_suppl). TPS174–TPS174. 1 indexed citations

19.

Tan, Angie Lay-Keng, Kakoli Das, Chia-Huey Ooi, et al.. (2011). Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.. 17(9). 2657–2667. 13 indexed citations

20.

Yan, Benedict, Chee Wee Ong, Kol Jia Yong, et al.. (2011). Clinical and therapeutic relevance of PIM1 kinase in gastric cancer. Gastric Cancer. 15(2). 188–197. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact